Intracranial hemorrhage medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Pharmacologic therapy in patients with intracranial hemorrhage includes the administration of agents to reverse the underlying coagulopathies. | Pharmacologic therapy in patients with intracranial hemorrhage includes the administration of agents to reverse the underlying coagulopathies. Other measures that should be taken into account while managing a patient with intracranial hemorrhage include the management of airway, intracranial pressure, and seizure. | ||
* Management of Seizure | |||
* Management of Airway | |||
==Medical Therapy== | ==Medical Therapy== | ||
Pharmacologic therapy in patients with intracranial hemorrhage include:<ref name="CaceresGoldstein2012">{{cite journal|last1=Caceres|first1=J. Alfredo|last2=Goldstein|first2=Joshua N.|title=Intracranial Hemorrhage|journal=Emergency Medicine Clinics of North America|volume=30|issue=3|year=2012|pages=771–794|issn=07338627|doi=10.1016/j.emc.2012.06.003}}</ref> | Pharmacologic therapy in patients with intracranial hemorrhage include:<ref name="CaceresGoldstein2012">{{cite journal|last1=Caceres|first1=J. Alfredo|last2=Goldstein|first2=Joshua N.|title=Intracranial Hemorrhage|journal=Emergency Medicine Clinics of North America|volume=30|issue=3|year=2012|pages=771–794|issn=07338627|doi=10.1016/j.emc.2012.06.003}}</ref> | ||
Revision as of 17:42, 18 June 2020
|
Intracranial hemorrhage Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Pharmacologic therapy in patients with intracranial hemorrhage includes the administration of agents to reverse the underlying coagulopathies. Other measures that should be taken into account while managing a patient with intracranial hemorrhage include the management of airway, intracranial pressure, and seizure.
- Management of Seizure
- Management of Airway
Medical Therapy
Pharmacologic therapy in patients with intracranial hemorrhage include:[1]
- Hemostatic therapy to correct the underlying coagulopathies. Agents that can be used to achieve this goal may differ based on the oral anticoagulant agent which resulted in the bleeding complications.
- The following agents can be used for warfarin reversal:[2][3][4]
- Fresh Frozen Plasma (FFP)
- Prothrombin Complex Concentrates (PCCs)
- Protamine sulfate is another agent that can be used for heparin-induced Intracranial hemorrhage.[5]
Other measures that should be taken into account while managing a patient with intracranial hemorrhage include:
- Management of Intracranial Pressure
- Management of Seizure
- Management of Airway
References
- ↑ Caceres, J. Alfredo; Goldstein, Joshua N. (2012). "Intracranial Hemorrhage". Emergency Medicine Clinics of North America. 30 (3): 771–794. doi:10.1016/j.emc.2012.06.003. ISSN 0733-8627.
- ↑ Steiner, Thorsten; Rosand, Jonathan; Diringer, Michael (2006). "Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy". Stroke. 37 (1): 256–262. doi:10.1161/01.STR.0000196989.09900.f8. ISSN 0039-2499.
- ↑ Goldstein, Joshua N.; Thomas, Stephen H.; Frontiero, Virginia; Joseph, Annelise; Engel, Chana; Snider, Ryan; Smith, Eric E.; Greenberg, Stephen M.; Rosand, Jonathan (2006). "Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage". Stroke. 37 (1): 151–155. doi:10.1161/01.STR.0000195047.21562.23. ISSN 0039-2499.
- ↑ Holland, Lorne; Warkentin, Theodore E.; Refaai, Majed; Crowther, Mark A.; Johnston, Marilyn A.; Sarode, Ravindra (2009). "Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose". Transfusion. 49 (6): 1171–1177. doi:10.1111/j.1537-2995.2008.02080.x. ISSN 0041-1132.
- ↑ Holst, J; Lindblad, B; Bergqvist, D; Garre, K; Nielsen, H; Hedner, U; Østergaard, P B (1994). "Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin™). An experimental investigation in healthy volunteers". Blood Coagulation & Fibrinolysis. 5 (5): 795–803. doi:10.1097/00001721-199410000-00018. ISSN 0957-5235.